Status of equine stem cell-based veterinary medicine in the UK

09 Nov 2019

Saville, V.

Vet Record Image

The Veterinary Medicines Directorate (VMD) would like to highlight to vets the stem cell-based veterinary medicines available in the UK for horses.

Two stem cell-based veterinary medicines become first to be granted EU-wide marketing authorisa-tion

Earlier this year, two stem cell-based veterinary medicines – Arti Cell Forte (Boehringer Ingelheim) and HorStem (EquiCord) – were the first to be granted EU-wide marketing authorisation. Arti Cell Forte is authorised for the reduction of mild to moderate recurrent lameness associated with non-septic joint inflammation in horses. HorStem is authorised for the reduction of lameness associated with mild to moderate degenerative joint disease (osteoarthritis) in horses. Both medicines are composed of allogeneic stem cells. As authorised medicines, they have undergone rigorous scientific assessment to ensure they are safe, effective and meet specified quality standards. Table 1 gives the classification of stem cell-based veterinary medical products.

Allogeneic and xenogeneic stem cell-based medicines require...